Aus Bio Scientific Panel
For several years Aus Bio has retained an internationally recognized Scientific Advisory Panel to assist the Company when needed in R & D issues. Membership of this Panel is as follows –
Professor Myron M, Levine, M.D., D.T.P.H., is Director of the Center for Vaccine Development of the University of Maryland School of Medicine, where he is professor of Medicine and Pediatrics and Head of the Division of Geographic Medicine. Professor Levine has for many years been a consultant to the World Health Organization, NIH, Institute of Medicine and the US Department of Defense.
Professor Levine has authored/co-authored 464 articles in peer reviewed medical and scientific journals and more than 97 chapters in leading textbooks. He is the Senior Editor of “New Generation Vaccines”, the leading text of research vaccinology, with the 4th edition to be published in early 2008. He is a member of the Institute of Medicine of the National Academy of Sciences, USA. Among the societies to which he has been elected are the Institute of Medicine of the National Academy of Sciences, USA, the American Epidemiology Society (President 2001), the American Society of Clinical Microbiology, the Infectious Diseases Society of America, and the President of the American Society of Tropical Medicine and Hygiene (President 2005-2006). Among Professor Levine’s many awards is the Albert B. Sabin Gold Medal from the Sabin Foundation for his contributions to the discipline of vaccinology and, in 2005, was awarded the rank of “Grand Officer of the National Order of Mali” presented on behalf of the President of Mali, Amadou Toumani Touré, for efforts in developing and distributing vaccines to the children of Mali.
Professor Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path) is from the Victorian Infectious Diseases Reference Laboratory (VIDRL, originally Fairfield Hospital Laboratory) where he has worked since 1989. He was Director of Laboratory Services from 1990-1998 and then assumed the position of Head, Research & Molecular Development of VIDRL. He is also Director of World Health Organisation Collaborating Centre for Virus Reference & Research. His current major research interests include viral hepatitis and antiviral chemotherapy with an emphasis on the basic virology of the various agents of hepatitis, the molecular pathogenesis of hepatitis, as well as prevention and public health control measures. The treatment of hepatitis B and C infections with antiviral agents represents the greatest challenge. Other research interests include SARS, sexually transmitted diseases of man especially infections associated with the AIDS virus, herpes virus and the human papillomaviruses. He is also interested in intellectual property issues when applied to clinical virology.
Professor Locarnini is the recipient of numerous awards including the Third Malaysian Liver Foundation Award and the Bristol Myers Squibb Freedom to Discover Award. He is author of more than 160 peer-reviewed articles, 11 invited editorials and over 60 book chapters and reviews and has delivered a number of invited and plenary lectures at major conferences.
Professor Locarnini has appointments at both Melbourne and Monash Universities, as well as Hong Kong University. He is on a number of Scientific Advisory Boards of a number of pharmaceutical and biotechnology companies. He is an Editor for Antiviral Therapy and on the Editorial Board of Antiviral Chemistry and Chemotherapy, Antiviral Research and Antimicrobial Agents & Chemotherapy.
Dr. John G. McHutchison, MD, FRACP, is Associate Director, Duke Clinical Research Institute, Director of the Gastroenterology/ Hepatology Research Program, and Professor of Medicine in the Division of Gastroenterology at Duke University Medical Center in Durham, North Carolina.
Dr. McHutchison has published worldwide in the field of liver diseases, and is the author of more than 200 articles related to liver disease, and more specifically, chronic hepatitis C infection. Dr. McHutchison also serves on the Editorial Board for Hepatology and is an Associate Editor for the Journal of Hepatology. Dr. McHutchison is currently a member of the AGA Research Policy Committee and Chairman of the American Association for the Study of Liver Diseases Clinical Research Committee.
Dr. McHutchison is a Fellow of the Royal Australian College of Physicians and is a member of several professional organizations, including the American Association of the Study of Liver Diseases, the European Association for Study of Liver Diseases and the American Gastroenterology Association. He received his MD degree (1981) from the University of Melbourne, Australia, and completed his internship, residency, and gastroenterology fellowship at the Royal Melbourne Hospital in Australia. He then completed an advanced fellowship in hepatology at the University of Southern California in Los Angeles. For the 10 years prior to moving to Duke University in 2002, he was the Medical Director of Liver Transplantation and head of the Hepatitis Study section at the Scripps Clinic and Research Foundation in La Jolla, California.
His primary research interests are related to clinical and translational research as they pertain to early drug development, immunopathogenesis and development of predictive models and systems as they pertain to disease progression, fibrosis and response to anti-viral therapy.
Professor Roy Robins-Browne, MB, BCh, DTM&H, PhD, FRCPA, FRCPath, FASM, is Professor and Deputy Head of the Department of Microbiology and Immunology at the University of Melbourne, and joint head of the Infectious Diseases and Microbiology Research Group at the Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne. He is also an Honorary Professor of Medicine at the University of Maryland School of Medicine in Baltimore, MD, USA. His chief interests are medical education and research. His particular research interests are infectious diseases, bacterial pathogenesis, molecular bacteriology and epidemiology, and antimicrobial chemotherapy. He has authored or co-authored more than 20 chapters in professional reference works, as well as more than 160 original research papers.